Active, Not Recruiting
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
NCT03634540
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States
- Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States
- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
- Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States